CARE Home
CARE Members
Status of Studies

The CARE-UTI Study
(The Urinary Track Infections study)

a multinational e-mail/web-based study
Copyright ©2002, CARE-UTI
Background Research Question Sampling of Investigators Sampling of Study Patients Clinical Examination
Required Diagnostic Laboratory Tests Data Recording and Submission Data Analysis Timeline Reporting of Results

 

Background

    For women, much is known about the risk factors, presentation, and treatment of urinary tract infections. While men get urinary tract symptoms also, the state of knowledge is much less about their risk factors and clinical presentation. Unfortunately, much of the clinical examination is not efficient at identifying which women have urinary tract infection. The baseline prevalence of asymptomatic bacteriuria is so high among women, that the clinical examination is not particularly useful for stratifying patients into those more or less likely to have a culture-proven urinary tract infection. This information may not generalize at all to men.

Research question

    Among men with an array of symptoms that prompt consideration of a urinary tract infection (non-chlamydial), what are the risk factors, symptoms, and examination findings that make a culture-proven infection more, or less, likely.

Sampling of Investigators

Sampling of Patients

    Patients must be men who have:

    Exclusion criteria:

Clinical Examination

    See attached data collection sheet

Required Diagnostic Laboratory Tests

    Urinalysis (must use method that assays for nitrates and leukocyte esterase). Investigators should submit the name of their laboratory's dipstick brand to the Coordinating Centre.

    Urine culture for bacteria. Chlamydia cultures will not be performed.

Data Recording and Submission

Data Analysis

    Sensitivity, specificity, and LRs for each of the findings will be assessed. A multivariate analysis will also be done to look for combinations of findings that might be useful. If a model is found, bootstrap regression to assess the confidence limits of the model will be assessed.

Timeline

    Enrollment to continue until we have enrolled 100 patients with UTI or at least 1 year.

Reporting of Results

Submitted by Ken Goldberg and David Simel, Durham, NC USA

* Any comments or concerns about this protocol, please email carestudy@rogers.com.


CARE Home
CARE Members
Status of Studies